JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

Search

Intuitive Surgical Inc

Geschlossen

BrancheGesundheitswesen

471.65 0.36

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

468.33

Max

475.46

Schlüsselkennzahlen

By Trading Economics

Einkommen

-45M

658M

Verkäufe

187M

2.4B

KGV

Branchendurchschnitt

67.603

34.393

EPS

1.81

Gewinnspanne

26.984

Angestellte

15,638

EBITDA

268M

987M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+28.25% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

16. Okt. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-12B

173B

Vorheriger Eröffnungskurs

471.29

Vorheriger Schlusskurs

471.65

Nachrichtenstimmung

By Acuity

10%

90%

5 / 374 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Weak Bearish Evidence

Intuitive Surgical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

22. Juli 2025, 21:13 UTC

Ergebnisse

Intuitive Surgical Logs Higher Profit, Revenue in 2Q

22. Apr. 2025, 20:55 UTC

Ergebnisse

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

23. Jan. 2025, 21:41 UTC

Ergebnisse

Intuitive Surgical Posts Higher 4Q Profit, Revenue on Continued Procedure Growth

21. Jan. 2025, 18:37 UTC

Akquisitionen, Fusionen, Übernahmen

Intuitive to Establish Direct Presence in Europe With Acquisition

22. Juli 2025, 20:14 UTC

Ergebnisse

Intuitive Surgical Sees FY25 Non-GAAP Gross Profit Margin to Be Within Range of 66% and 67% >ISRG

22. Juli 2025, 20:13 UTC

Ergebnisse

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15.5% to 17% >ISRG

22. Juli 2025, 20:13 UTC

Ergebnisse

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 10,488 Systems as of June 30 >ISRG

22. Juli 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 2Q Net $658.4M >ISRG

22. Juli 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 2Q Da Vinci Surgical Systems Shipped 395.00 >ISRG

22. Juli 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 2Q Rev $2.44B >ISRG

22. Juli 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 2Q Adj EPS $2.19 >ISRG

22. Juli 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 2Q EPS $1.81 >ISRG

22. Apr. 2025, 20:13 UTC

Ergebnisse

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

22. Apr. 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 1Q EPS $1.92 >ISRG

22. Apr. 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

22. Apr. 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 1Q Net $698.4M >ISRG

22. Apr. 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

22. Apr. 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 1Q Rev $2.25B >ISRG

24. Jan. 2025, 21:17 UTC

Ergebnisse

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

24. Jan. 2025, 18:18 UTC

Ergebnisse

Intuitive Surgical Stock Drops After Earnings Beat. Wall Street Is Still Optimistic. -- Barrons.com

24. Jan. 2025, 13:11 UTC

Top News

Dow Jones Futures Fall Ahead Of Inflation Data; 5 Tech Giants To Buy And Watch -- IBD

24. Jan. 2025, 09:51 UTC

Heiße Aktien

Stocks to Watch Friday: Texas Instruments, CSX, Burberry, American Express -- WSJ

23. Jan. 2025, 21:10 UTC

Ergebnisse

Intuitive Surgical Expects Non-GAAP Gross Profit Margin to Be Within 67% and 68% of Net Rev in 2025 >ISRG

23. Jan. 2025, 21:09 UTC

Ergebnisse

Intuitive Surgical Expects Worldwide Da Vinci Procedures to Increase 13% to 16% in 2025 >ISRG

23. Jan. 2025, 21:09 UTC

Ergebnisse

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 9,902 Systems as of Dec 31 >ISRG

23. Jan. 2025, 21:05 UTC

Ergebnisse

Intuitive Surgical 4Q Adj EPS $2.21 >ISRG

23. Jan. 2025, 21:05 UTC

Ergebnisse

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 493.00 >ISRG

23. Jan. 2025, 21:05 UTC

Ergebnisse

Intuitive Surgical 4Q Rev $2.41B >ISRG

23. Jan. 2025, 21:05 UTC

Ergebnisse

Intuitive Surgical 4Q Net $685.7M >ISRG

23. Jan. 2025, 21:05 UTC

Ergebnisse

Intuitive Surgical 4Q EPS $1.88 >ISRG

Peer-Vergleich

Kursveränderung

Intuitive Surgical Inc Prognose

Kursziel

By TipRanks

28.25% Vorteil

12-Monats-Prognose

Durchschnitt 602.89 USD  28.25%

Hoch 685 USD

Tief 440 USD

Basierend auf 22 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Intuitive Surgical Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

22 ratings

17

Buy

4

Halten

1

Sell

Technischer Score

By Trading Central

514.59 / 539.05Unterstützung & Widerstand

Kurzfristig

Weak Bearish Evidence

Mittelfristig

Weak Bullish Evidence

Langfristig

Strong Bullish Evidence

Stimmung

By Acuity

5 / 374 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.